High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates
- PMID: 18006808
- DOI: 10.1158/0008-5472.CAN-07-0539
High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates
Abstract
Gene expression analysis has identified biologically relevant subclasses of breast cancer. However, most classification schemes do not robustly cluster all HER2+ breast cancers, in part due to limitations and bias of clustering techniques used. In this article, we propose an alternative approach that first separates the HER2+ tumors using a gene amplification signal for Her2/neu amplicon genes and then applies consensus ensemble clustering separately to the HER2+ and HER2- clusters to look for further substructure. We applied this procedure to a microarray data set of 286 early-stage breast cancers treated only with surgery and radiation and identified two basal and four luminal subtypes in the HER2- tumors, as well as two novel and robust HER2+ subtypes. HER2+ subtypes had median distant metastasis-free survival of 99 months [95% confidence interval (95% CI), 83-118 months] and 33 months (95% CI, 11-54 months), respectively, and recurrence rates of 11% and 58%, respectively. The low recurrence subtype had a strong relative overexpression of lymphocyte-associated genes and was also associated with a prominent lymphocytic infiltration on histologic analysis. These data suggest that early-stage HER2+ cancers associated with lymphocytic infiltration are a biologically distinct subtype with an improved natural history.
Similar articles
-
Breast cancer stratification from analysis of micro-array data of micro-dissected specimens.Genome Inform. 2007;18:130-40. Genome Inform. 2007. PMID: 18546481
-
Predicting features of breast cancer with gene expression patterns.Breast Cancer Res Treat. 2008 Mar;108(2):191-201. doi: 10.1007/s10549-007-9596-6. Epub 2007 May 22. Breast Cancer Res Treat. 2008. PMID: 18297396
-
The complexity of genotypic alterations underlying HER2-positive breast cancer: an explanation for its clinical heterogeneity.Curr Opin Oncol. 2007 Nov;19(6):552-7. doi: 10.1097/CCO.0b013e3282f0ad8e. Curr Opin Oncol. 2007. PMID: 17906451 Review.
-
Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome.Cancer Res. 2003 Apr 1;63(7):1445-8. Cancer Res. 2003. PMID: 12670887
-
Molecular subtypes of breast cancers detected in mammography screening and outside of screening.Clin Cancer Res. 2008 Jul 1;14(13):4103-10. doi: 10.1158/1078-0432.CCR-07-5003. Clin Cancer Res. 2008. PMID: 18593987
Cited by
-
Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer.Front Oncol. 2023 Jun 12;13:1108472. doi: 10.3389/fonc.2023.1108472. eCollection 2023. Front Oncol. 2023. PMID: 37377907 Free PMC article.
-
Effect of neoadjuvant chemotherapy on tumor immune infiltration in breast cancer patients: Systematic review and meta-analysis.PLoS One. 2023 Apr 27;18(4):e0277714. doi: 10.1371/journal.pone.0277714. eCollection 2023. PLoS One. 2023. PMID: 37104271 Free PMC article.
-
Identification of Breast Cancer Subtypes by Integrating Genomic Analysis with the Immune Microenvironment.ACS Omega. 2023 Mar 21;8(13):12217-12231. doi: 10.1021/acsomega.2c08227. eCollection 2023 Apr 4. ACS Omega. 2023. PMID: 37033796 Free PMC article.
-
Comparison of the prognostic value of stromal tumor-infiltrating lymphocytes and CD3 + T cells between schistosomal and non-schistosomal colorectal cancer.World J Surg Oncol. 2023 Feb 1;21(1):31. doi: 10.1186/s12957-023-02911-3. World J Surg Oncol. 2023. PMID: 36726115 Free PMC article.
-
Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures.Genes (Basel). 2022 Dec 23;14(1):44. doi: 10.3390/genes14010044. Genes (Basel). 2022. PMID: 36672784 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous